QIAGEN N.V. to Release Results for Q3 2022 and Hold Webcast

Rhea-AI Summary

QIAGEN N.V. (NYSE: QGEN) announced it will release its third-quarter 2022 results on November 7 at 22:05 Frankfurt time. A conference call for discussion will occur the following day, November 8, at 15:00 Frankfurt time. Participants can join via a callback registration, phone dial-in, or by accessing an audio webcast. QIAGEN, based in the Netherlands, provides solutions enabling molecular insights from biological samples, supporting over 500,000 customers globally.

Positive

• Scheduled release of Q3 2022 results indicates ongoing transparency and communication with investors.
• Conference call allows for direct engagement with stakeholders, enhancing investor relations.

Negative

• None.

VENLO, Netherlands--(BUSINESS WIRE)-- QIAGEN N.V. (NYSE: QGEN) (Frankfurt Stock Exchange: QIA) announced its plans to release results for the third quarter of 2022.

Press release date / time: Monday, November 7, shortly after 22:05 Frankfurt time / 21:05 London time / 16:05 New York time.

Conference call date / time: Tuesday, November 8, at 15:00 Frankfurt time / 14:00 London time / 09:00 New York time.

Three options for joining the conference call

Register for call back connection   Click here: Connect me   Service available 15 minutes before call start

Dial-in by phone     +1 646 828 8073 (U.S.) +44 (0)330 165 4012 (UK) +49 (0)69 22222 5197 (GER)   To avoid waiting time, please join the event conference 5-10 minutes prior to the start time.   Conference ID: 6981929

Access the audio webcast   Click here: Access Webcast

A conference call replay will be available by using the following link:
https://globalmeet.webcasts.com/starthere.jsp?ei=1565383&tp_key=5dca096fdf

Contact: IR@qiagen.com

About QIAGEN

QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies make these biomolecules visible and ready for analysis. Bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. Automation solutions tie these together in seamless and cost-effective workflows. QIAGEN provides solutions to more than 500,000 customers around the world in Molecular Diagnostics (human healthcare) and Life Sciences (academia, pharma R&D and industrial applications, primarily forensics). As of June 30, 2022, QIAGEN employed more than < 6,100 people in over 35 locations worldwide. Further information can be found at http://www.qiagen.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20221021005213/en/

John Gilardi

Vice President, Head of Corporate Communications and Investor Relations

+49 2103 29 11711

+1 240 686 2222

Email: ir@qiagen.com

Phoebe Loh

Senior Director Investor Relations

+49 2103 29 11457

Email: ir@qiagen.com

Source: QIAGEN N.V.

FAQ

When will QIAGEN release its Q3 2022 results?

QIAGEN will release its Q3 2022 results on November 7, 2022.

What time is the Q3 2022 results conference call for QIAGEN?

The conference call for QIAGEN's Q3 2022 results will take place on November 8, 2022, at 15:00 Frankfurt time.

How can I join QIAGEN's Q3 results conference call?

You can join the conference call by registering for a callback, dialing in by phone, or accessing the audio webcast.

What is the stock symbol for QIAGEN?

The stock symbol for QIAGEN is QGEN.